-+ 0.00%
-+ 0.00%
-+ 0.00%

Climb Bio Q3 EPS $(0.18) Beats $(0.20) Estimate

Benzinga·11/05/2026 12:39:19
Diffusion vocale
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 5.26 percent increase over losses of $(0.19) per share from the same period last year.